When was MarraBio founded?

MarraBio was founded in 2011 and raised its 1st funding round 12 years after it was founded.

Where is MarraBio located?

MarraBio is headquartered in Newcastle Upon Tyne, United Kingdom. It is registered at SANDGATE HOUSE,102 QUAYSIDE,NEWCASTLE UPON TYNE,TYNE AND WEAR,ENGLAND,NE1 3DX.

Who is the current CEO of MarraBio?

Daniel Peters of MarraBio. They have also founded 1 company.

Which legal entities is MarraBio associated with?

MarraBio is associated with MARRABIO LIMITED.

How many employees does MarraBio have?

As of Mar 31, 2025, the latest employee count at MarraBio is 9.

Is MarraBio a funded company?

MarraBio is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Sep 19, 2023.

How much is MarraBio worth?

The latest valuation of MarraBio is £***** as of Sep 10, 2025.

When was the latest funding round of MarraBio?

MarraBio's latest funding was a $***** Seed round on Sep 19, 2023, with participation from 4 investors. Its primary sector is Life Sciences Platforms and Tools. In United Kingdom, the Life Sciences Platforms and Tools sector has seen $141M in funding in 2026 to date.

Where does MarraBio rank among its competitors?

MarraBio ranks 8th amongst 93 active competitors, of which 19 are funded. It stands 10th in terms of total funding among its competitors. The most recent competitor to raise funding was Qkine, which secured $2.03M in Sep, 2026.

Who are the top competitors of MarraBio?

MarraBio's top competitors include Qkine, Laigo Biotechnology and Core Biogenesis. Among them, Qkine secured the most recent funding round in September, 2026.

MarraBio - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Biotechnology research company that provides bacterial protein polymers. It specializes in creating engineered Caf1 proteins that offer xeno-free alternative to the extracellular matrix proteins and growth factors used in mammalian cell culture for biotechnology research. It is used for research, agricultural or therapeutic use.

Website: marrabio.com
Phone Number: +44 **********
Registered Address: SANDGATE HOUSE,102 QUAYSIDE,NEWCASTLE UPON TYNE,TYNE AND WEAR,ENGLAND,NE1 3DX

Key Metrics

Founded Year

2011

Location

Newcastle Upon Tyne, United Kingdom

Stage

Seed

Latest Funding Round

Seed, Sep 19, 2023, $*****

Post Money Valuation

£***** as on Sep 10, 2025

Investors

Maven Capital Partners & 3 more

Ranked

8^th among 93 active competitors

Employee Count

9 as on Mar 31, 2025

Similar Companies

Qkine & 94 more

View MarraBio's full profile

MarraBio is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
MARRABIO LIMITED CIN: 14289165 , United Kingdom, Active	Aug 09, 2022	-	9 (As on Mar 31, 2025)

MarraBio has raised funding over 1 round. Its latest funding round was a Seed round on Sep 19, 2023 for $*****. 4 investors participated in its latest round. MarraBio has 4 institutional investors.

Here is the list of recent funding rounds of MarraBio:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 19, 2023	6769981	Seed	6660036	3816828	5179954	9339115

Access funding benchmarks and valuations. Sign up today!

View details of MarraBio's funding rounds and investors

The founders of MarraBio are Helen Waller, Jeremy Lakey and Daniel Peters. Daniel Peters is the CEO of MarraBio.

Here are the details of MarraBio's key team members:

Helen Waller: Co-Founder & CTO of MarraBio. They serve on the board of 1 company.
Contact Info: 1 email address
Jeremy Lakey: Co-Founder & CSO of MarraBio.
Contact Info: 1 email address
Daniel Peters: Co-Founder & CEO of MarraBio.
Contact Info: 1 email address

MarraBio's Board of Directors

MarraBio's board has 4 active members. Helen Waller, Aidan Benedict Courtney, Jeremy Hugh Lakey and Daniel Thomas Peters are part of team.

Here is the list of MarraBio's board of directors:

Name	Type	Representing	Status	Duration
Helen Waller	Team	-	Current	3y 4m
Aidan Benedict Courtney	Team	-	Current	4y 2m
Jeremy Hugh Lakey	Team	-	Current	4y 2m
Daniel Thomas Peters	Team	-	Current	4y 2m

View details of MarraBio's Founder profiles and Board Members

MarraBio's employee count trend

MarraBio has 9 employees as of Mar 25. The total employee count is 50.0% more than what it was in Mar 24. Here is MarraBio's employee count trend over the years:

Uncover MarraBio's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of MarraBio include Qkine, Laigo Biotechnology and Core Biogenesis. Here is the list of Top 10 competitors of MarraBio, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Qkine 2016, Cambridge (United Kingdom), Series A	Developer of animal-free growth factors for life science applications	$10.2M	Parkwalk, Downing Ventures & 21 others	61/100
2nd	Laigo Biotechnology 2023, Utrecht (Netherlands), Seed	Developer of targeted protein degradation technology for therapeutic applications	$19.8M	Kurma Partners, Curie Capital & 8 others	53/100
3rd	Core Biogenesis 2020, Paris (France), Series A	Provider of UBaaS platform for recombinant protein bioproduction	$14.1M	Plug and Play Tech Center, Entrepreneurs First ... & 6 others	49/100
4th	Future Fields 2017, Edmonton (Canada), Series A	Biomanufacturing unit for serum-free, bioactive growth factors, and other recombinant proteins	$21.6M	Bee Partners, Toyota Ventures & 21 others	46/100
5th	Xias Bio 2020, United States, Seed	Developer of recombinant proteins	$5.23M	IndieBio, SOSV & 4 others	41/100
6th	Orf Genetics 2001, Kopavogur (Iceland), Series A	Developer of recombinant protein technology	$5.87M	EIC Fund, Europa	40/100
7th	KAICO 2018, Fukuoka (Japan), Series B	Manufacturer of portfolio of proteins and other biological cytokines and enzymes	$8.15M	ITOCHU Technology Ventures, Tokyo Century ... & 8 others	38/100
8th	MarraBio 2011, Newcastle Upon Tyne (United Kingdom), Seed	Biotechnology research company that provides bacterial protein polymers	-	Maven Capital Partners, Northstar Ventures ... & 2 others	37/100
9th	Hunan Zhongsheng Quanpeptide Biotechnology 2017, Zhuzhou (China), Series B	Developer of peptide discovery technology, peptide libraries, and related research products	$47.9M	CDH, Xjsci & 7 others	37/100
10th	Algenex 2005, Madrid (Spain), Series B	Developer of recombinant biologics for animal and human health	$13.3M	Columbus Venture Partners, Vita Advisory & 1 others	35/100